Stockscreener 앱 받기
41.07
2.52%
1.01
전일 마감가:
$40.06
열려 있는:
$40.06
하루 거래량:
182.29K
Relative Volume:
0.66
시가총액:
$1.66B
수익:
$982.01M
순이익/손실:
$14.80M
주가수익비율:
111.00
EPS:
0.37
순현금흐름:
$37.02M
1주 성능:
+4.13%
1개월 성능:
+1.66%
6개월 성능:
+34.48%
1년 성능:
+96.23%
1일 변동 폭
$40.02
$41.60
1주일 범위
$38.71
$41.60
52주 변동 폭
$16.16
$46.42
Phibro Animal Health Corp Stock (PAHC) Company Profile
명칭
Phibro Animal Health Corp
전화
201-329-7300
주소
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
PAHC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
41.07 | 1.62B | 982.01M | 14.80M | 37.02M | 0.37 |
|
ZTS
Zoetis Inc
|
124.65 | 55.21B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.16 | 51.59B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.83 | 43.51B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.76 | 37.11B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
464.93 | 20.32B | 3.08B | 1.24B | 1.07B | 25.61 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-06-16 | 업그레이드 | BNP Paribas Exane | Underperform → Neutral |
| 2024-09-10 | 개시 | JP Morgan | Neutral |
| 2023-12-07 | 개시 | Exane BNP Paribas | Underperform |
| 2022-12-21 | 개시 | ROTH Capital | Buy |
| 2022-07-25 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-01-10 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2021-11-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-08-05 | 재개 | Credit Suisse | Neutral |
| 2021-07-07 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2020-08-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2020-01-28 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-09-05 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | 재확인 | BofA/Merrill | Underperform |
| 2019-06-11 | 개시 | Barclays | Underweight |
| 2019-05-23 | 개시 | Guggenheim | Neutral |
| 2019-05-09 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2017-08-23 | 재개 | BofA/Merrill | Underperform |
| 2017-06-02 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | 개시 | Piper Jaffray | Overweight |
| 2016-11-11 | 다운그레이드 | Macquarie | Neutral → Underperform |
| 2016-11-10 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2016-04-11 | 재확인 | Guggenheim | Buy |
| 2016-02-04 | 개시 | Credit Suisse | Outperform |
| 2016-01-15 | 다운그레이드 | Barclays | Overweight → Underweight |
| 2015-09-30 | 개시 | Gabelli & Co | Buy |
| 2015-04-24 | 재확인 | Barclays | Overweight |
| 2015-04-21 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | 개시 | Barclays | Overweight |
모두보기
Phibro Animal Health Corp 주식(PAHC)의 최신 뉴스
Phibro Animal Health (PAHC) director sells $569k in shares - Investing.com
Phibro Animal Health (PAHC) director sells $569k in shares By Investing.com - Investing.com Australia
Reasons to Add Fresenius Medical Stock to Your Portfolio Now - Finviz
Phibro Animal Health Stock Climbs 90.9% in a Year: What's Driving It? - Yahoo Finance
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now - Finviz
Phibro (PAHC) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Here's Why Phibro Animal Health (PAHC) is a Strong Growth Stock - Yahoo Finance
Glycolic Acid Market is expected to generate a revenue of USD 461.74 Million by 2032, Globally, at 5.73% CAGR: Verified Market Research® - GlobeNewswire Inc.
BFI Co sells Phibro Animal Health (PAHC) shares for $8554 - Investing.com India
Assessing Phibro Animal Health (PAHC) Valuation After Recent Share Price Strength - Yahoo Finance
Is Phibro Animal Health (PAHC) Pricing Reflecting Its Strong Multi Year Share Price Performance? - Yahoo Finance
3 Reasons Why Growth Investors Shouldn't Overlook Phibro (PAHC) - Yahoo Finance
BFI Co sells Phibro Animal Health (PAHC) shares worth $13,148 By Investing.com - Investing.com Nigeria
BFI Co sells Phibro Animal Health (PAHC) shares worth $13,148 - Investing.com
Is Phibro Animal Health (PAHC) a Great Value Stock Right Now? - Yahoo Finance
Can Phibro Animal Health Corporation stock deliver consistent earnings growthFibonacci Extensions & Free Daily Stock Hotspot Analysis - Улправда
Phibro Animal Health Corporation (NASDAQ:PAHC) Receives Average Rating of “Hold” from Analysts - Defense World
Phibro Animal Health (NASDAQ:PAHC) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings - Yahoo Finance
Trend Dashboard Flags Symbiox Investment Trading Co Ltd As Potential Swing TradeDividend Stability Analysis & Free Explosive Earning Power - earlytimes.in
Phibro Animal Health Corporation (NASDAQ:PAHC) Receives Average Rating of "Hold" from Analysts - MarketBeat
BFI Co sells Phibro Animal Health (PAHC) shares for $8554 By Investing.com - Investing.com UK
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now - Finviz
Reasons to Retain Baxter International Stock in Your Portfolio Now - Finviz
Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
Phibro Animal Health (STU:PB8) EV-to-OCF : 27.56 (As of Dec. 23, 2025) - GuruFocus
Phibro Animal Health (PAHC): Assessing Valuation After a Recent Pullback and Strong Year-to-Date Rally - simplywall.st
Published on: 2025-12-21 06:36:24 - Улправда
Is Phibro Animal Health Corporation stock resilient to inflation2025 Valuation Update & Daily Profit Maximizing Trade Tips - Улправда
Phibro Animal Health (PAHC): Rethinking Valuation After a 95% Year-to-Date Surge and Recent Pullback - Yahoo Finance
Phibro Animal Health says Daniel Bendheim to assume CEO role in July - MSN
Phibro Animal Health (NASDAQ:PAHC) Shares Gap DownHere's What Happened - MarketBeat
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock - Yahoo Finance
Why hedge funds are buying Phibro Animal Health Corporation stockWeekly Gains Report & Risk Managed Investment Strategies - DonanımHaber
Is Phibro Animal Health Corporation stock a defensive play in 20252025 Breakouts & Breakdowns & Risk Adjusted Buy/Sell Alerts - DonanımHaber
Is Phibro Animal Health Corporation stock supported by strong fundamentalsTrade Volume Summary & AI Forecast Swing Trade Picks - Улправда
Phibro Animal Health Corp. Announces Leadership Transition - citybiz
Leadership Changes at Phibro Animal Health (PAHC) Aim to Drive F - GuruFocus
Phibro Animal Health announces leadership transition - Feedstuffs
Phibro Animal Health announces CEO transition effective July 2026 - Investing.com
Phibro Animal Health Names Dani Bendheim as CEO, Jack Bendheim Becomes Executive Chairman - marketscreener.com
Phibro Animal Health Corporation Announces Chief Executive Officer Changes, Effective July 1, 2026 - marketscreener.com
Phibro Animal Health (PAHC) plans CEO handoff to Dani Bendheim in 2026 - Stock Titan
Phibro Animal Health Corporation Announces Leadership Transition - Yahoo Finance
Is It Too Late to Consider Phibro After a 95% Surge in 2025? - simplywall.st
Is Phibro Animal Health Stock a Smart Addition to Your Portfolio Now? - Yahoo Finance
Phibro Animal Health (PAHC) CEO details Rule 10b5-1 insider stock sales - Stock Titan
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance
Research Analysts Set Expectations for PAHC FY2026 Earnings - MarketBeat
Is Phibro Animal Health Still Attractive After a 94% Surge in 2025? - Yahoo Finance
Why is Phibro (PAHC) down 5.3% since last earnings report? - MSN
Jack Bendheim Sells 1,288 Shares of Phibro Animal Health (NASDAQ:PAHC) Stock - MarketBeat
Phibro Animal Health Corp (PAHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.30%
1.45%
자본화:
|
볼륨(24시간):